Loading...
Loading...
MIRO| Name | Value |
|---|---|
| Revenues | 4.0K |
| Cost of Revenue | 125.0K |
| Gross Profit | -121.0K |
| Operating Expense | 8,113.4K |
| Operating I/L | -8,234.5K |
| Other Income/Expense | 52.3K |
| Interest Income | 61.1K |
| Pretax | -8,182.2K |
| Income Tax Expense | 68.8K |
| Net Income/Loss | -8,251.0K |
Miromatrix Medical Inc. is a life sciences company specializing in bioengineering fully transplantable organs. The company's proprietary technology utilizes a two-step method of decellularization and recellularization to remove porcine cells from organs obtained from pigs and replace them with unmodified human cells. Miromatrix Medical Inc. generates revenue through collaborations with leading medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute, where its innovative organ bioengineering technology is utilized for research and development purposes.
